Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether medicines funded through the cancer drugs fund are included in the calculation of the rebate due under the voluntary pricing scheme for branded medicines (VPAS).

The Cancer Drugs Fund (CDF) helps to ensure that patients are able to benefit from the most promising new cancer medicines while further evidence is collected on their use to address clinical uncertainty.

Funding for the CDF is allocated from NHS England budgets. Unless specifically exempt under scheme rules, sales of products within the CDF are included in measured sales when calculating sales growth used to set the voluntary scheme for branded medicines pricing and access payment percentage each year and included in eligible sales used to calculate the amount owed by the relevant scheme member each quarter.